Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Interim analysis of oxicity and response in phase 1 trial of systemic targeted alpha therapy for metastatic melanoma

Academic Article
uri icon
  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Raja, C.
  • Graham, P.
  • Rizvi, S. M. A.
  • Song, E.
  • Goldsmith, H.
  • Thompson, J.
  • Bosserhoff, A.
  • Morgenstern, A.
  • Apostolidis, C.
  • Kearsley, J.
  • Reisfeld, Ralph
  • Allen, B. J.

publication date

  • June 2007

journal

  • Cancer Biology & Therapy  Journal

subject areas

  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Cohort Studies
  • Disease Progression
  • Female
  • Humans
  • Immunotherapy
  • Male
  • Melanoma
  • Middle Aged
  • Neoplasm Metastasis
  • Pentetic Acid
  • Tomography, Emission-Computed, Single-Photon
scroll to property group menus

Research

keywords

  • Bi-213
  • alpha radiation
  • melanoma
  • metastasis
  • monoclonal antibody 9.2.27
  • response
  • targeted alpha therapy
  • toxicity
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 1538-4047

PubMed ID

  • 17495524
scroll to property group menus

Additional Document Info

start page

  • 846

end page

  • 852

volume

  • 6

issue

  • 6

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support